Haoqi Pan

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Laparoscopic Delivery of a MnO2-P-ICG Patch for Photodynamic Therapy and NK Cell-Driven Immunotherapy in Hepatocellular Carcinoma.

Laparoscopic Delivery of a MnO2-P-ICG Patch for Photodynamic Therapy and NK Cell-Driven Immunotherapy in Hepatocellular Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 09, 2025

Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential.

Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential.

Journal: Biomarker research

Published: October 17, 2025

Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition.

Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition.

Journal: Gut

Published: June 26, 2025

ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer.

ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer.

Journal: Gastroenterology

Published: March 27, 2025

Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trial.

Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trial.

Journal: Signal transduction and targeted therapy

Published: July 09, 2024

TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality.

TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality.

Journal: Gut

Published: May 03, 2024

Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer.

Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer.

Journal: British journal of cancer

Published: December 31, 2023

NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy.

NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy.

Journal: Cell death & disease

Published: October 25, 2023

Histone lactylation: from tumor lactate metabolism to epigenetic regulation.

Histone lactylation: from tumor lactate metabolism to epigenetic regulation.

Journal: International journal of biological sciences

Published: October 24, 2023

Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progress.

Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progress.

Journal: Frontiers in endocrinology

Published: January 30, 2022

GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis in the treatment of inflammatory bowel disease.

GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis in the treatment of inflammatory bowel disease.

Journal: Bioactive materials

Published: December 20, 2021

Whole-exon sequencing insights into pancreatic synovial sarcoma: a case report.

Whole-exon sequencing insights into pancreatic synovial sarcoma: a case report.

Journal: Gland surgery

Published: June 24, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026